Sociopath Community

I can understand feeling a bit sus about Bill Gates and Big Pharma, but would Dolly Parton really do you dirty like that?

Outro said: 

I can understand feeling a bit sus about Bill Gates and Big Pharma, but would Dolly Parton really do you dirty like that?

 

 Why would you think I would care about some celebrity getting vaccinated? I'm not manipulated by what others do. That's for sheep.

Look, I'm not anti vaxx. I'm fully vaccinated against other pathogens. and I had covid already so don't need a covid vaccine. These ass hole narc money chasing scientist are making me anti vaxx.

I'm anti poor science. These scientist that developed the new "experimental" vaccines forgot about the variable of time. I get that there was a fake emergency. I get that.

Fess up to the mistakes and stop the experimental vaccines.

FFS! The vaccines weren't rushed. They're based on research done a decade ago that was amped up during the MERS virus outbreak. MERS is a coronavirus that shares 50% of the genetic properties of COVID. It took 7 years for the vaccines they use for COVID-19 to be researched. Most of the work was already done when COVID hit. That's how they were made so fast. 

https://www.cbc.ca/news/canada/newfoundland-labrador/apocalypse-then-vaccine-speed-1.6008611

copy/pasta if you're interested:

"Jason McLellan, a molecular bioscientist based at the University of Texas at Austin, had been working on vaccine development for several years by the time MERS appeared on the epidemiological landscape, and he wondered whether the severe new illness could be prevented through vaccination.

To help on the project, he recruited graduate student Daniel Wrapp and postdoctoral researcher Nianshuang Wang, who, for his doctoral thesis at Tsinghua University, had worked out the structure of MERS' spike protein.

Coronaviruses are named for the crown (or corona) of spikes that cover their outer surfaces. McLellan and his team wanted to find a way to manufacture MERS' spike protein by itself, without the virus attached to it. If they could do that, they theorized, they could teach the body's immune system to recognize and attack the spike without ever having to expose the body to the deadly virus itself.

They faced a serious challenge. Coronavirus spikes change shape when they interact with human cells, making them too unstable to reproduce. After years of making one tiny genetic tweak after another, the team finally found the right combination of modifications to lock MERS' spike protein into a consistent shape, a tremendous step toward creating a vaccine.

Much to their surprise, though, none of the top scientific journals were interested in their findings. It took them a full year to publish their results. Other researchers just didn't think MERS and other coronaviruses were that important at the time.

By then, MERS had slowed to only a couple hundred cases per year, and the overall risk from coronaviruses seemed low. Most health officials expected the next global pandemic to come in the form of a new strain of influenza.

All that changed at the beginning of 2020. In the first few days of January, McLellan was snowboarding with his family when his phone rang. It was a collaborator giving him a heads-up that a strange new coronavirus was circulating in the city of Wuhan.

Given the seriousness of MERS and SARS before it, they both knew that a coronavirus outbreak could spell trouble. McLellan alerted his team members that they would be jumping into analyzing this new virus as soon as they had more information.

A few days later, Chinese researchers published the genome of the virus online, and McLellan's lab, like researchers around the world, went to work. Trials started 2 months after genome was sequenced. 

It was Jan. 10, the day before China confirmed its first death from COVID-19. It would be another two weeks before Wuhan entered lockdown and two months before the WHO declared a pandemic.

Armed with the techniques they'd already developed, it took McLellan and his team only an hour to figure out how to stabilize the new virus' spike protein. Soon they began shipping their fixed version of the protein to other labs around the world.

It would be used as the basis for the Moderna, Pfizer-BioNTech, Johnson & Johnson, and Novavax vaccines.

 That record-breaking speed was possible only because of technologies that had already been perfected. The vaccines took not one but seven years to develop.

Thanks to MERS, McLellan and his lab were prepared to rapidly respond to a new coronavirus. If the pandemic had been caused by another type of pathogen, like an arenavirus, we might still be waiting for a vaccine."

MissCommunication said: 

FFS! The vaccines weren't rushed.

Are you telling me you agree with Trump and project warp speed? He push these vaccines out too fast.

This is the first mass mRNA vaccine delivery method ever used on humans, first ever, they didn't tell you that did they? Trump rushed it for the election.

Of course, I agree, SARS COV vaccine research has been going on for years.

Some think SarsCov2 is a self disseminating vaccine lab escape, see other thread

Understanding mRNA COVID-19 Vaccines

mRNA vaccines are a new type of vaccine to protect against infectious diseases.

https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/mrna.html

The guy in the pdf is much better with words than I am

"

Why weren’t serious adverse events identified before vaccines were rolled out?

Problems like anaphylactic shock (a severe allergic reaction) and potentially fatal blood
clots were not identified until most of the experimental COVID-19 vaccines were used widely
among the public 5, 6 . Janssen’s study of the Johnson & Johnson vaccine did suggest some
propensity for blood clotting. As for anaphylactic reactions, people with a history of allergies were
excluded from the earlier clinical trials.

Another reason why some problems were not identified earlier is because short-cuts were
taken with the traditional approach to vaccine research. Specifically, the time taken to assess
safety was too short. Instead of taking the usual ~4-10 years to undergo thorough in vitro (i.e.,
benchtop) tests, pre-clinical (i.e., animal) studies, and then sequential clinical testing (i.e., human
Phase 1, 2 and 3 trials), COVID-19 vaccines were developed and assessed for safety and efficacy
in less than one year. This meant that only very short-term safety scenarios could be evaluated.
Of equal concern, the number of people that were evaluated in clinical trials was too small to
capture rare but dangerous side-effects. This is unfortunate, because we have seen in Canada
that rare but serious problems can lead to a vaccine program being suspended. Indeed, in
Canada, a risk of blood clots for the AstraZeneca vaccine of 1 out of every 55,000 people
vaccinated was deemed to be too dangerous, leading to its use being halted. Authorization under
Interim Order for COVID-19 vaccines was granted after they were evaluated for a short duration
in about 20,000 people. This means these studies could, at best, detect serious side effects that
would occur in at least 1 out of every 20,000 people. In other words, the study design included a
test population that was too small to identify vaccines that may be too dangerous for Canadians.

"